Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Novel use proposed for EGCg: inhibition of HIV-1

Sep. 25, 1998

Lobucavir is safe and effective in controlling herpes recurrences

Sep. 24, 1998

Postmarketing study of Vaqta supports safety of hepatitis A vaccine

Sep. 24, 1998

Independent investigators report efficacy of Eisai cephalosporin

Sep. 24, 1998

Safety studies support pediatric use of MKC-442

Sep. 24, 1998

Meiji Seika profiles preclinical activity of new parenteral cephalosporin

Sep. 24, 1998

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

Sep. 24, 1998

Energostim improves brain energy metabolism in infarct patients

Sep. 23, 1998

Antidepressant efficacy demonstrated with amantadine

Sep. 23, 1998

Wealth of clinical data support efficacy of ziprasidone

Sep. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...